CC
TNYA icon

Commodore Capital’s Tenaya Therapeutics TNYA Stock Holding History

Commodore Capital’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-357,699
Closed -$2.01M – 32
2022
Q2 		$2.01M Sell
357,699
-156,231
-30% -$1.26M 0.43% 23
2022
Q1 		$6.05M Hold
513,930
– – 1.35% 20
2021
Q4 		$9.74M Hold
513,930
– – 2.26% 16
2021
Q3 		$10.6M Buy
+513,930
New +$11M 2.8% 15

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commodore Capital's TNYA Position: Q3 2022 in Review

Commodore Capital sold out of Tenaya Therapeutics (TNYA) in Q3 2022, closing a stake of 357,699 shares — an estimated $2.01M sold.

Commodore Capital first reported a position in TNYA in Q3 2021 and held it in 4 quarters. The position peaked at $10.6M in Q3 2021. 73 funds tracked by Wall St. Rank hold TNYA as of Q3 2022.

  • Commodore Capital reported no remaining Tenaya Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Commodore Capital sold 357,699 Tenaya Therapeutics shares in Q3 2022, an estimated $2.01M.
  • Commodore Capital first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 4 quarters.
  • Commodore Capital's Tenaya Therapeutics position peaked at $10.6M in Q3 2021.
  • 73 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2022.

Based on Commodore Capital's 13F filing for Q3 2022, filed 14 Nov 2022.